Eugenio Barone

Pubblicazioni

Titolo Pubblicato in Anno
Intranasal administration of KYCCSRK peptide rescues brain insulin signaling activation and reduces Alzheimer’s disease-like neuropathology in a mouse model for Down syndrome ANTIOXIDANTS 2023
A Bioengineering Strategy to Control ADAM10 Activity in Living Cells INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Engineering memory with an extrinsically disordered kinase SCIENCE ADVANCES 2023
Brain insulin resistance: An early risk factor for Alzheimer's disease development in down syndrome NEURAL REGENERATION RESEARCH 2022
Aberrant protein networks in Alzheimer disease NATURE REVIEWS. NEUROLOGY 2022
CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down syndrome FREE RADICAL BIOLOGY & MEDICINE 2022
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling SCIENCE SIGNALING 2022
Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Insulin Signaling Regulates Mitochondrial Bioenergetics in the Brain: Insight for the Development of Neurodegenerative Diseases FREE RADICAL BIOLOGY & MEDICINE 2022
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome FREE RADICAL BIOLOGY & MEDICINE 2021
High-fat diet leads to reduced protein o-glcnacylation and mitochondrial defects promoting the development of alzheimer’s disease signatures INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles ALZHEIMER'S & DEMENTIA 2021
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control LIFE SCIENCES 2021
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease FREE RADICAL BIOLOGY & MEDICINE 2021
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder FREE RADICAL BIOLOGY & MEDICINE 2021
Editorial: Brain insulin resistance in neurodevelopmental and neurodegenerative disorders: mind the gap! FRONTIERS IN NEUROSCIENCE 2021
Valorization of tomato waste as a source of carotenoids MOLECULES 2021
Building the future therapies for down syndrome: the third international conference of the T21 research society MOLECULAR SYNDROMOLOGY 2021
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome NEUROBIOLOGY OF DISEASE 2020

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma